Evaluation of the Efficacy of Levetiraceteam Plus Iron in Comparison With Iron Alone in Controlling and Reducing the Frequency of Breath-Holding Spells in Children Aged 6 Months to 5 Years
Iranian Journal of Child Neurology,
Vol. 14 No. 4 (2020),
1 October 2020
,
Page 43-53
https://doi.org/10.22037/ijcn.v14i4.25777
Abstract
Ojective
A breath-holding spell (BHS) is defined as an apnea attack following an initial stressful event like anger, sadness, and fear, a painful event like falling or head trauma or any stressful psychology event. This study was designed to assess the comparative efficacy of levetiracetam plus iron and iron alone in reducing the BHS frequency in children aged 6 months to 5 years
Materials & Methods
This study was designed as a double-blinded randomized clinical trial. Sixty patients aged 6 months to 5 years were assigned into two groups, with the first group (A) receiving only iron and the second group (B) receiving levetiracetam plus iron. At the end of the study, the efficacy of therapy was analyzed comparatively in these groups
Results
In this study, the mean number of attacks was 3.94 ± 2.69 before treatment and 1.71 ± 1.99 after treatment in the group A, while it was 6.39 ± 5.7 before treatment and 0.37 ± 1.03after treatment in the group B. The mean number of attacks after treatment was lower in group B than in group A. In fact, there was a significant difference between the two groups in terms of the number of attacks after treatment (P = 0.003).
Conclusion
Levetiracetam plus iron is more effective than iron alone in reducing breath-holding spells in children aged 6 months to 5 years.
- Breath-Holding spells
- Levetiracetam
- Iron supplements
How to Cite
References
Leung AK, Leung AA, Wong AH, Hon KL. Breath-Holding Spells in Pediatrics: A Narrative Review of the Current Evidence. Current pediatric reviews. 2019;15(1):22-9.
Calik M, Abuhandan M, Aycicek A, Taskin A, Selek S, Iscan A. Increased oxidant status in children with breath-holding spells. Child's Nervous System. 2013;29(6):1015-9.
Patel AD, Berg AT, Billinghurst L, Fain D, Fecske E, Feyma T, et al. Quality improvement in neurology: child neurology quality measure set: executive summary. Neurology. 2018;90(2):67-73.
Bhavanishankar R, Ramu P, Chaitanya N. CLINICAL AND EPIDEMIOLOGICAL PROFILE OF BREATH HOLDING SPELLS (BHS)-AN ANALYSIS OF 115 CASES. Journal of Evolution of Medical and Dental Sciences. 2018;7(4):534-40.
Jain R, Omanakuttan D, Singh A, Jajoo M. Effect of iron supplementation in children with breath holding spells. Journal of paediatrics and child health. 2017;53(8):749-53.
Tomoum H, Habeeb N, Elagouza I, Mobarez H. Paediatric breath‐holding spells are associated with autonomic dysfunction and iron deficiency may play a role. Acta Paediatrica. 2018;107(4):653-7.
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nature Reviews Neuroscience. 2015;16(6):358.
Zhang W, Wang C, Zou R, Liu L, Wu L, Luo X, et al. Changes in P-wave, T-wave, and ST segment amplitude in 12 lead electrocardiogram in children with breath holding spell. Zhong nan da xue xue bao Yi xue ban= Journal of Central South University Medical sciences. 2016;41(6):600-5.
Hussain S, Afzal M, Imam SM, Sabir MU, Tarar SH, Asghar I. Breath holding spells: demographic profile and efficacy of iron supplementation in children with breath holding spells and anemia on reduction in frequency of these spells. Pain. 2016;15:33.3.
Goldman RD. Breath-holding spells in infants. Canadian Family Physician. 2015;61(2):149-50.
Rezaeian S, Ahmadzadeh J, Esmailnasab N, Veisani Y, Shayan M, Moradi N. Assessment of health and nutritional status in children based on school screening programs. 2014;3(1):15-21
Donma MM. Clinical efficacy of piracetam in treatment of breath-holding spells. Pediatric neurology. 1998;18(1):41-5.
Jain P, Gulati P, Morrison-Levy N, Yau I, Alsowat D, Otsubo H, et al. “Breath holding spells” in a child with SCN8A-related epilepsy: Expanding the clinical spectrum. Seizure-European Journal of Epilepsy. 2019;65:129-30.
Cramer JA, Arrigo C, Van Hammée G, Gauer LJ, Cereghino JJ, Group NS. Effect of Levetiracetam on Epilepsy‐Related Quality of Life. Epilepsia. 2000;41(7):868-74.
Akpinar M, Ocal M, İrdem A. Ventricular repolarization changes in children with breath holding spells. Journal of Electrocardiology. 2019;55:116-9
Mocan H, Yildiran A, Orhan F, Erduran E. Breath holding spells in 91 children and response to treatment with iron. Archives of disease in childhood. 1999;81(3):261-2.
Azam M, Bhatti N, Shahab N. Piracetam in severe breath holding spells. The International Journal of Psychiatry in Medicine. 2008;38(2):195-201.
Fisher R, Saul M. Overview of epilepsy. Stanford Neurology. 2010 p.29.
Ghareib BA, Khalil M, Gaber DM. A comparative study of the efficacy of using piracetam with iron therapy versus iron therapy alone in children with breath-holding spells. Alexandria Journal of Pediatrics. 2017;30(1):26.
Bolat N, Eliacik K, Sargin E, Kanik A, Baydan F, Sarioglu B. Efficacy of a Brief Psychoeducational Intervention for Mothers of Children with Breath-Holding Spells: A Randomized Controlled Pilot Trial. Neuropediatrics. 2016;47(04):226-32.
- Abstract Viewed: 308 times